Global Vascular Closure Devices Market Size Study & Forecast, by Type, Access, Procedure and Regional Forecasts 2025-2035

Description

The Global Vascular Closure Devices Market, valued at approximately USD 1.1 billion in 2024, is anticipated to expand at a steady CAGR of 7.00% from 2025 to 2035, reaching an estimated USD 2.32 billion. Vascular closure devices (VCDs) have emerged as pivotal tools in modern interventional procedures, allowing clinicians to rapidly achieve hemostasis after catheterization while minimizing patient discomfort and enabling faster ambulation. Their adoption is increasingly favored over traditional manual compression due to shorter recovery times, reduced vascular complications, and improved patient throughput in hospitals. Growth is being driven by the surge in minimally invasive cardiovascular procedures, rising prevalence of coronary artery disease, and an aging population that presents a higher demand for catheter-based diagnostics and interventions. Additionally, the integration of next-generation biomaterials and resorbable technologies has bolstered clinical outcomes, thereby strengthening market penetration.

The pace of innovation within the vascular closure space is being accelerated by strategic investments from leading medical device companies aiming to enhance device safety, ease of use, and compatibility with smaller sheath sizes. The shift toward radial access, while initially a limiting factor for some femoral-focused closure devices, has spurred the development of radial-specific VCDs, widening the addressable market. According to the American Heart Association, cardiovascular diseases remain the leading cause of mortality globally, underscoring the need for procedural efficiency and complication reduction in interventional cardiology. Moreover, the growing volume of interventional radiology and vascular surgery cases-driven by increased screening and early diagnosis-is further stimulating demand. However, challenges such as high device costs in low-income regions, the need for trained personnel, and occasional device-related complications may temper growth trajectories in certain geographies.

From a geographical perspective, North America commanded the largest market share in 2024, supported by advanced healthcare infrastructure, a high procedural volume of percutaneous interventions, and rapid adoption of innovative closure technologies. The United States, in particular, benefits from strong reimbursement frameworks and a high concentration of key industry players. Europe follows closely, driven by favorable regulatory environments, rising cardiovascular procedure rates, and growing adoption of same-day discharge protocols in cardiac catheterization labs. Meanwhile, Asia Pacific is projected to experience the fastest growth over the forecast period, spurred by expanding healthcare access, increased government investment in cardiac care facilities, and rising incidence of cardiovascular disease in rapidly urbanizing nations such as China and India. The Middle East & Africa, though currently a smaller market, is poised for gradual expansion through healthcare modernization programs and strategic collaborations with international device manufacturers.

Major market player included in this report are:

Abbott Laboratories
Terumo Corporation
Cardinal Health, Inc.
Teleflex Incorporated
Boston Scientific Corporation
Merit Medical Systems, Inc.
Medtronic plc
Vasorum Ltd.
Haemonetics Corporation
Vivasure Medical Ltd.
Cardiva Medical, Inc.
Morris Innovative, Inc.
TZ Medical, Inc.
Essential Medical, Inc.
VasClosure Inc.

Global Vascular Closure Devices Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Type:

Passive Approximators
Active Approximators
External Hemostatic Devices

By Access:

Femoral
Radial

By Procedure:

Interventional Cardiology
Interventional Radiology/Vascular Surgery

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global Vascular Closure Devices Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. key Findings

Chapter 3. Global Vascular Closure Devices Market Forces Analysis

3.1. Market Forces Shaping The Global Vascular Closure Devices Market (2024-2035)
3.2. Drivers
- 3.2.1. (Escalating minimally invasive procedures and rising coronary artery disease prevalence)
- 3.2.2. (Advances in biomaterials, resorbable technologies, and radial-specific VCD designs)
3.3. Restraints
- 3.3.1. (High device costs and limited access in low-income settings)
- 3.3.2. (Training requirements, device-related complications, and regulatory scrutiny)
3.4. Opportunities
- 3.4.1. (Growth in interventional radiology/vascular surgery and same-day discharge protocols)
- 3.4.2. (Accelerating adoption across Asia Pacific amid rising CVD burden and healthcare investments)

Chapter 4. Global Vascular Closure Devices Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Vascular Closure Devices Market Size & Forecasts by Type 2025-2035

5.1. Market Overview
5.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
5.3. Passive Approximators
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
5.4. Active Approximators
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
5.5. External Hemostatic Devices
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Vascular Closure Devices Market Size & Forecasts by Application 2025-2035

6.1. Market Overview
6.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
6.3. Interventional Cardiology
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
6.4. Interventional Radiology/Vascular Surgery
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Vascular Closure Devices Market Size & Forecasts by Region 2025-2035

7.1. Growth Hormone Deficiency Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Vascular Closure Devices Market
- 7.3.1. U.S. Vascular Closure Devices Market
  - 7.3.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.3.1.2. Application breakdown size & forecasts, 2025-2035
- 7.3.2. Canada Vascular Closure Devices Market
  - 7.3.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.3.2.2. Application breakdown size & forecasts, 2025-2035
7.4. Europe Vascular Closure Devices Market
- 7.4.1. UK Vascular Closure Devices Market
  - 7.4.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.1.2. Application breakdown size & forecasts, 2025-2035
- 7.4.2. Germany Vascular Closure Devices Market
  - 7.4.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.2.2. Application breakdown size & forecasts, 2025-2035
- 7.4.3. France Vascular Closure Devices Market
  - 7.4.3.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.3.2. Application breakdown size & forecasts, 2025-2035
- 7.4.4. Spain Vascular Closure Devices Market
  - 7.4.4.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.4.2. Application breakdown size & forecasts, 2025-2035
- 7.4.5. Italy Vascular Closure Devices Market
  - 7.4.5.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.5.2. Application breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe Vascular Closure Devices Market
  - 7.4.6.1. Type breakdown size & forecasts, 2025-2035
  - 7.4.6.2. Application breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Vascular Closure Devices Market
- 7.5.1. China Vascular Closure Devices Market
  - 7.5.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.1.2. Application breakdown size & forecasts, 2025-2035
- 7.5.2. India Vascular Closure Devices Market
  - 7.5.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.2.2. Application breakdown size & forecasts, 2025-2035
- 7.5.3. Japan Vascular Closure Devices Market
  - 7.5.3.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.3.2. Application breakdown size & forecasts, 2025-2035
- 7.5.4. Australia Vascular Closure Devices Market
  - 7.5.4.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.4.2. Application breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea Vascular Closure Devices Market
  - 7.5.5.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.5.2. Application breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC Vascular Closure Devices Market
  - 7.5.6.1. Type breakdown size & forecasts, 2025-2035
  - 7.5.6.2. Application breakdown size & forecasts, 2025-2035
7.6. Latin America Vascular Closure Devices Market
- 7.6.1. Brazil Vascular Closure Devices Market
  - 7.6.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.6.1.2. Application breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico Vascular Closure Devices Market
  - 7.6.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.6.2.2. Application breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Vascular Closure Devices Market
- 7.7.1. UAE Vascular Closure Devices Market
  - 7.7.1.1. Type breakdown size & forecasts, 2025-2035
  - 7.7.1.2. Application breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) Vascular Closure Devices Market
  - 7.7.2.1. Type breakdown size & forecasts, 2025-2035
  - 7.7.2.2. Application breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa Vascular Closure Devices Market
  - 7.7.3.1. Type breakdown size & forecasts, 2025-2035
  - 7.7.3.2. Application breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies
8.2. Abbott Laboratories
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
8.3. Terumo Corporation
8.4. Cardinal Health, Inc.
8.5. Teleflex Incorporated
8.6. Boston Scientific Corporation
8.7. Merit Medical Systems, Inc.
8.8. Medtronic plc
8.9. Vasorum Ltd.
8.10. Haemonetics Corporation
8.11. Vivasure Medical Ltd.
8.12. Cardiva Medical, Inc.
8.13. Morris Innovative, Inc.
8.14. TZ Medical, Inc.
8.15. Essential Medical, Inc.
8.16. VasClosure Inc.